In the STEP (Semaglutide Treatment Effect in People with Obesity) program, participants achieved an average weight loss of up to 15% of their body weight
[15] However, subsequent analysis revealed important context: the increased risk was predominantly observed in patients with pre-existing diabetic retinopathy and those who experienced rapid improvements in glycaemic control
If you're on Medicare: As of 2026, Medicare coverage for GLP-1 weight loss drugs remains limited, though there have been ongoing discussions in Congress about expanding it
By using a telehealth-based model, we connect you with licensed providers who can monitor your progress and adjust your program based on how your body is responding
A 2.5 mg/mL preparation gives 0.25 mg in 10 units, 0.5 mg in 20 units, and so on
There are compounded versions of GLP-1 medications, but FDA officials issued a The Biden administration placed There have been Ali said there are indications that certain peptides could be beneficial